BN83495

Known as: Steroid Sulfatase Inhibitor BN 83495 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2007-2011
012320072011

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Structure-activity relationship studies were conducted on Irosustat (STX64, BN83495), the first steroid sulfatase (STS) inhibitor… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?
Review
2011
Review
2011
Hydrolysis of biologically inactive steroid sulfates to unconjugated steroids by steroid sulfatase (STS) is strongly implicated… (More)
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
Review
2011
Review
2011
Steroid sulfatase plays a pivotal role in regulating the formation of biologically active steroids from inactive steroid sulfates… (More)
  • figure 1
Is this relevant?
2008
2008
The past few years have seen an increase in the reported incidence of endometrial carcinoma, one of the most frequently diagnosed… (More)
Is this relevant?
2008
2008
Steroid sulphatase (STS) inhibitors have been developed primarily for the treatment of hormone-dependent breast cancer, but may… (More)
Is this relevant?
Review
2007
Review
2007
Inhibitors of steroid sulfatase are being developed as a novel therapy for hormone-dependent breast cancer in postmenopausal… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?